2015

1. Bendamustine, bortezomib and prednisone for the treatment of patients with newly diagnosed multiple myeloma: Results of a prospective phase 2 Spanish/PETHEMA trial

   Haematologica, Vol. 100, Núm. 8, pp. 1096-1102

2. Zoledronic acid as compared with observation in multiple myeloma patients at biochemical relapse: Results of the randomized AZABACHE Spanish trial

   Haematologica, Vol. 100, Núm. 9, pp. 1207-1213